TY - JOUR
T1 - Efectos de la hipertensión pulmonar en la capacidad de ejercicio en pacientes con enfermedad pulmonar obstructiva crónica
AU - Blanco, Isabel
AU - Valeiro, Beatriz
AU - Torres-Castro, Rodrigo
AU - Barberán-García, Anael
AU - Torralba, Yolanda
AU - Moisés, Jorge
AU - Sebastián, Laura
AU - Osorio, Jeisson
AU - Rios, José
AU - Gimeno-Santos, Elena
AU - Roca, Josep
AU - Barberà, Joan A.
N1 - Publisher Copyright:
© 2019 The Author(s)
PY - 2020/8
Y1 - 2020/8
N2 - Introduction: The impact of pulmonary hypertension (PH) on exercise tolerance in chronic obstructive pulmonary disease (COPD) has not been fully elucidated. It is necessary to characterize pulmonary hemodynamics in patients with moderate to severe COPD in order to improve their management. The aim of the study was to determine whether in COPD the presence of PH is associated with reduced exercise tolerance in a cohort of stable COPD patients. Methods: Cross-sectional analysis of 174 COPD patients clinically stable: 109 without PH and 65 with PH (COPD-PH). We assessed socio-demographic data, lung function, quality of life, dyspnea, cardiopulmonary exercise testing (CPET), constant workload endurance time (CWET), and six-minute walk test (6MWT). We elaborated a logistic regression model to explore the impact of PH on exercise capacity in COPD patients. Results: COPD-PH patients showed lower exercise capacity both at maximal (CPET) (43(20) versus 68(27) Watts and 50(19)% versus 71(18)% predicted peak oxygen consumption (VO2peak), COPD-PH and COPD, respectively), and at submaximal tests (6MWT) (382(94) versus 486(95) m). In addition, the COPD-PH group had lower endurance time than the non-PH COPD group (265(113) s and 295(164) s, respectively). Conclusions: The presence of PH is an independent factor that impairs exercise capacity in COPD.
AB - Introduction: The impact of pulmonary hypertension (PH) on exercise tolerance in chronic obstructive pulmonary disease (COPD) has not been fully elucidated. It is necessary to characterize pulmonary hemodynamics in patients with moderate to severe COPD in order to improve their management. The aim of the study was to determine whether in COPD the presence of PH is associated with reduced exercise tolerance in a cohort of stable COPD patients. Methods: Cross-sectional analysis of 174 COPD patients clinically stable: 109 without PH and 65 with PH (COPD-PH). We assessed socio-demographic data, lung function, quality of life, dyspnea, cardiopulmonary exercise testing (CPET), constant workload endurance time (CWET), and six-minute walk test (6MWT). We elaborated a logistic regression model to explore the impact of PH on exercise capacity in COPD patients. Results: COPD-PH patients showed lower exercise capacity both at maximal (CPET) (43(20) versus 68(27) Watts and 50(19)% versus 71(18)% predicted peak oxygen consumption (VO2peak), COPD-PH and COPD, respectively), and at submaximal tests (6MWT) (382(94) versus 486(95) m). In addition, the COPD-PH group had lower endurance time than the non-PH COPD group (265(113) s and 295(164) s, respectively). Conclusions: The presence of PH is an independent factor that impairs exercise capacity in COPD.
KW - Cardiopulmonary exercise test
KW - Chronic obstructive pulmonary disease
KW - Exercise tolerance
KW - Pulmonary hypertension
KW - Six-minute walk test
UR - http://www.scopus.com/inward/record.url?scp=85076208590&partnerID=8YFLogxK
U2 - 10.1016/j.arbres.2019.10.015
DO - 10.1016/j.arbres.2019.10.015
M3 - Artículo
C2 - 31771920
AN - SCOPUS:85076208590
SN - 0300-2896
VL - 56
SP - 499
EP - 505
JO - Archivos de Bronconeumologia
JF - Archivos de Bronconeumologia
IS - 8
ER -